Ethical issues of psychotropic medication for people with intellectual disabilities

被引：11

作者：

Raghavan, Raghu ^{[1
]}

Patel, Pradip ^{[2
]}

机构：

[1] Northumbria Univ, Sch Hlth Commun & Educ Studies, Newcastle Upon Tyne, Tyne & Wear, England

[2] Lancashire Care NHS Fdn Trust, Preston, Lancs, England

来源：

ADVANCES IN MENTAL HEALTH AND INTELLECTUAL DISABILITIES | 2010年 / 4卷 / 03期

关键词：

learning disabilities; intellectual disability; medication; ethical and legal issues;

D O I：

10.5042/amhid.2010.0541

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

There is over-use of psychotropic medication with people with intellectual disabilities. Many of these individuals do not have the capacity to understand and retain the relevant information about the use and effectiveness of medication. Professionals and health care practitioners need to be fully aware of the ethical and legal issues in the use and administration of psychotropic medication.

引用

页码：34 / 38

页数：5

共 17 条

[1]

[Anonymous], 2008, CONS PAT DOCT MAK DE

[2]

Arnold L E, 1993, Ann Clin Psychiatry, V5, P189, DOI 10.3109/10401239309148982

[3]

CLARKE DJ, 1990, J MENT DEFIC RES, V34, P385

[4]

Cookson J., 2002, USE DRUGS PSYCHIAT

[5] A SELF-RATING SCALE FOR MEASURING NEUROLEPTIC SIDE-EFFECTS - VALIDATION IN A GROUP OF SCHIZOPHRENIC-PATIENTS [J].

DAY, JC ;

WOOD, G ;

DEWEY, M ;

BENTALL, RP .

BRITISH JOURNAL OF PSYCHIATRY, 1995, 166 :650-653

[6] THE USE OF PSYCHOTROPIC MEDICATION IN PEOPLE WITH LEARNING-DISABILITY - TOWARDS RATIONAL PRESCRIBING [J].

DEB, S ;

FRASER, W .

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1994, 9 (04) :259-272

[7]

Deb S., 2006, USING MEDICATION MAN

[8]

DH (Dept of Health), 2001, VAL PEOPL NEW STRAT

[9]

Hall S., 2008, ADV MENT HLTH LEARN, V2, P29, DOI [10.1108/17530180200800005, DOI 10.1108/17530180200800005]

[10]

Holland A, 2003, SEM PSYCH LEARN DIS

← 1 2 →